Evidence map›Paper›PMID 36643042›Full record

ArticleJournal of clinical and translational hepatology2023

MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver Cirrhosis.

Feng-Yong Liu, Ming Shi, Xin Li, Hong-Jun Yuan, Xiao-Mei Tian, Yi-Mao Xia, Min Zhou, Fu-Sheng Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Feng-Yong LiuChinese PLA Medical School, Beijing, China.
Ming ShiSenior Department of Infectious Diseases, Fifth Medical Center of PLA General Hospital, Beijing, China.
Xin LiDepartment of Interventional Radiology, Senior Department of Oncology, Fifth Medical Center of PLA General Hospital, Beijing, China.
Hong-Jun YuanDepartment of Interventional Radiology, Senior Department of Oncology, Fifth Medical Center of PLA General Hospital, Beijing, China.
Xiao-Mei TianChinese PLA Medical School, Beijing, China.
Yi-Mao XiaChinese PLA Medical School, Beijing, China.
Min ZhouInstitute of Translational Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Fu-Sheng WangChinese PLA Medical School, Beijing, China.ORCID https://orcid.org/0000-0002-8043-6685

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Stem cell transplantation is a potential treatment option for liver cirrhosis (LC). Accurately and noninvasively monitoring the distribution, migration, and prognosis of transplanted stem cells using imaging methods is important for in-depth study of the treatment mechanisms. Our study aimed to develop Au-Fe Methods: Au-Fe Results: Synthesized Au-Fe Conclusions: Au-Fe

Indexed as

Bone marrow-derived mesenchymal stem cellsDual-modal imagingLiver cirrhosisNanoparticlesStem cell tracking

Identifiers

PMID36643042
PMCPMC9817052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.